FDA Import Refusal SCS-3213794-9/11/1 — NEWPORT PHARMACEUTICALS
The FDA refused shipment SCS-3213794-9/11/1 from NEWPORT PHARMACEUTICALS (Costa Rica) on Apr 8, 2024. The refused product falls under Drugs and Biologics — DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY). Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 8, 2024
- Country
- Costa Rica
- Product Category
- Drugs and Biologics
- Product Code
- 62GCE90 DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY)
- Charges
- 118,3280,75